1. Home
  2. BEAM vs ATKR Comparison

BEAM vs ATKR Comparison

Compare BEAM & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • ATKR
  • Stock Information
  • Founded
  • BEAM 2017
  • ATKR 1959
  • Country
  • BEAM United States
  • ATKR United States
  • Employees
  • BEAM N/A
  • ATKR N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • ATKR Industrial Machinery/Components
  • Sector
  • BEAM Health Care
  • ATKR Miscellaneous
  • Exchange
  • BEAM Nasdaq
  • ATKR Nasdaq
  • Market Cap
  • BEAM 2.3B
  • ATKR 2.3B
  • IPO Year
  • BEAM 2020
  • ATKR 2016
  • Fundamental
  • Price
  • BEAM $22.21
  • ATKR $60.60
  • Analyst Decision
  • BEAM Strong Buy
  • ATKR Buy
  • Analyst Count
  • BEAM 11
  • ATKR 6
  • Target Price
  • BEAM $50.50
  • ATKR $103.17
  • AVG Volume (30 Days)
  • BEAM 2.3M
  • ATKR 712.3K
  • Earning Date
  • BEAM 05-06-2025
  • ATKR 05-06-2025
  • Dividend Yield
  • BEAM N/A
  • ATKR 2.11%
  • EPS Growth
  • BEAM N/A
  • ATKR N/A
  • EPS
  • BEAM N/A
  • ATKR 10.43
  • Revenue
  • BEAM $63,518,000.00
  • ATKR $3,065,169,000.00
  • Revenue This Year
  • BEAM N/A
  • ATKR N/A
  • Revenue Next Year
  • BEAM $6.32
  • ATKR $1.95
  • P/E Ratio
  • BEAM N/A
  • ATKR $5.81
  • Revenue Growth
  • BEAM N/A
  • ATKR N/A
  • 52 Week Low
  • BEAM $20.84
  • ATKR $55.91
  • 52 Week High
  • BEAM $35.25
  • ATKR $194.98
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 38.64
  • ATKR 38.35
  • Support Level
  • BEAM $21.60
  • ATKR $62.00
  • Resistance Level
  • BEAM $24.53
  • ATKR $64.97
  • Average True Range (ATR)
  • BEAM 1.64
  • ATKR 2.12
  • MACD
  • BEAM -0.24
  • ATKR 0.18
  • Stochastic Oscillator
  • BEAM 8.85
  • ATKR 7.44

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

Share on Social Networks: